Can a phone app curb suicide risk in troubled teens?

NCT ID NCT04909203

Completed Symptom relief Sponsor: Evidence-Based Practice Institute, Seattle, WA Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a paired smartphone app called iKinnect2.0 for teenagers aged 15–21 who are involved in the juvenile justice system and at risk for suicide. The app aims to help youth and their parents communicate better, manage distress, and prevent self-harm. Fifty-six parent-teen pairs used either the iKinnect2.0 app or a control app for 16 weeks, and researchers tracked changes in suicidal thoughts, coping skills, and family functioning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: iKinnect2.0 mobile phone app
What this could lead to: If it works, this could provide a practical tool to help at-risk youth and their families manage suicidal thoughts and behaviors.
What could go wrong: This is a small, early-stage trial with only 56 participants, so results may not apply broadly. The app's effectiveness is unproven, and it relies on consistent use by both youth and parents.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILD BEHAVIOR DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Child Behavior Disorders Self-Injurious Behavior Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILD BEHAVIOR DISORDERS SUICIDE AND SELF-HARM

Contacts and locations

Show contact details

Locations

Evidence-Based Practice Institute

Seattle, Washington, 98126, United States
University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.